APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Active Pharmaceutical Ingredients (API)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Veterinary Active Pharmaceutical Ingredients (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchVeterinary Active Pharmaceutical Ingredients (API) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Active Pharmaceutical Ingredients (API) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Veterinary Active Pharmaceutical Ingredients (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Active Pharmaceutical Ingredients (API) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Active Pharmaceutical Ingredients (API) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Veterinary Active Pharmaceutical Ingredients (API) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Veterinary Active Pharmaceutical Ingredients (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Active Pharmaceutical Ingredients (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Active Pharmaceutical Ingredients (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Veterinary Active Pharmaceutical Ingredients (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary Active Pharmaceutical Ingredients (API) include Qilu Pharmaceutical (Inner Mongolia) Co, Ltd, Jiangsu Lingyun Pharmaceutical Co. Ltd, SUANFARMAOfichem Group, Procyon Life Sciences, NGL Fine-Chem Ltd, Menadiona, lndukern Group, LasaSupergenerics Ltd. and Huvepharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Active Pharmaceutical Ingredients (API) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Active Pharmaceutical Ingredients (API) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Active Pharmaceutical Ingredients (API) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Active Pharmaceutical Ingredients (API) market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Active Pharmaceutical Ingredients (API) Segment by Company

Qilu Pharmaceutical (Inner Mongolia) Co, Ltd

Jiangsu Lingyun Pharmaceutical Co. Ltd

SUANFARMAOfichem Group

Procyon Life Sciences

NGL Fine-Chem Ltd

Menadiona

lndukern Group

LasaSupergenerics Ltd.

Huvepharma

Excel Veterinary HealthcareVetpharma(Insud Pharma)

Alivira Animal Health Ltd

Veterinary Active Pharmaceutical Ingredients (API) Segment by Type

Biological API

Chemical Based API

Highly Potent APl(HPAPI)

Veterinary Active Pharmaceutical Ingredients (API) Segment by Application

CDMO

CMO

Veterinary Active Pharmaceutical Ingredients (API) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Active Pharmaceutical Ingredients (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Active Pharmaceutical Ingredients (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Active Pharmaceutical Ingredients (API).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Active Pharmaceutical Ingredients (API) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Veterinary Active Pharmaceutical Ingredients (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Veterinary Active Pharmaceutical Ingredients (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Veterinary Active Pharmaceutical Ingredients (API) Industry Trends Table 2. Veterinary Active Pharmaceutical Ingredients (API) Industry Drivers Table 3. Veterinary Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges Table 4. Veterinary Active Pharmaceutical Ingredients (API) Industry Restraints Table 5. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers Table 9. Global Veterinary Active Pharmaceutical Ingredients (API) Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Veterinary Active Pharmaceutical Ingredients (API) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Veterinary Active Pharmaceutical Ingredients (API) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers, Product Type & Application Table 13. Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Active Pharmaceutical Ingredients (API) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Biological API Table 17. Major Manufacturers of Chemical Based API Table 18. Major Manufacturers of Highly Potent APl(HPAPI) Table 19. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (k units) Table 21. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2027-2032) & (k units) Table 22. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2021-2026) Table 23. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2027-2032) Table 24. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2026) & (k units) Table 26. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2027-2032) & (k units) Table 27. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2021-2026) Table 28. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of CDMO Table 30. Major Manufacturers of CMO Table 31. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (k units) Table 33. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2027-2032) & (k units) Table 34. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2021-2026) Table 35. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2027-2032) Table 36. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2026) & (k units) Table 38. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2027-2032) & (k units) Table 39. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2021-2026) Table 40. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2027-2032) Table 41. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2021-2026) & (k units) Table 43. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2021-2026) Table 44. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 48. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 49. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 51. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 58. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2021-2026) Table 62. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2027-2032) Table 63. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information Table 64. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Business Overview Table 65. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 67. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Development Table 68. Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information Table 69. Jiangsu Lingyun Pharmaceutical Co. Ltd Business Overview Table 70. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 72. Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Development Table 73. SUANFARMAOfichem Group Company Information Table 74. SUANFARMAOfichem Group Business Overview Table 75. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 77. SUANFARMAOfichem Group Recent Development Table 78. Procyon Life Sciences Company Information Table 79. Procyon Life Sciences Business Overview Table 80. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 82. Procyon Life Sciences Recent Development Table 83. NGL Fine-Chem Ltd Company Information Table 84. NGL Fine-Chem Ltd Business Overview Table 85. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 87. NGL Fine-Chem Ltd Recent Development Table 88. Menadiona Company Information Table 89. Menadiona Business Overview Table 90. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 92. Menadiona Recent Development Table 93. lndukern Group Company Information Table 94. lndukern Group Business Overview Table 95. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 97. lndukern Group Recent Development Table 98. LasaSupergenerics Ltd. Company Information Table 99. LasaSupergenerics Ltd. Business Overview Table 100. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 102. LasaSupergenerics Ltd. Recent Development Table 103. Huvepharma Company Information Table 104. Huvepharma Business Overview Table 105. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 107. Huvepharma Recent Development Table 108. Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information Table 109. Excel Veterinary HealthcareVetpharma(Insud Pharma) Business Overview Table 110. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 112. Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Development Table 113. Alivira Animal Health Ltd Company Information Table 114. Alivira Animal Health Ltd Business Overview Table 115. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 117. Alivira Animal Health Ltd Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Veterinary Active Pharmaceutical Ingredients (API) Distributors List Table 121. Veterinary Active Pharmaceutical Ingredients (API) Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Veterinary Active Pharmaceutical Ingredients (API) Product Image Figure 2. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (2021-2032) & (k units) Figure 5. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Veterinary Active Pharmaceutical Ingredients (API) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Biological API Image Figure 9. Chemical Based API Image Figure 10. Highly Potent APl(HPAPI) Image Figure 11. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2021-2032) Figure 14. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2021-2032) Figure 17. CDMO Image Figure 18. CMO Image Figure 19. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2021-2032) Figure 22. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2021-2032) Figure 25. North America Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2021-2032) Figure 27. U.S. Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2021-2032) Figure 32. Germany Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2021-2032) Figure 39. China Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2021-2032) Figure 47. Brazil Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Veterinary Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Figure 58. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Veterinary Active Pharmaceutical Ingredients (API) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Veterinary Active Pharmaceutical Ingredients (API) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Biological API
  • Chemical Based API
  • Highly Potent APl(HPAPI)
Applications
  • CDMO
  • CMO
Companies covered
  • Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
  • Jiangsu Lingyun Pharmaceutical Co. Ltd
  • SUANFARMAOfichem Group
  • Procyon Life Sciences
  • NGL Fine-Chem Ltd
  • Menadiona
  • lndukern Group
  • LasaSupergenerics Ltd.
  • Huvepharma
  • Excel Veterinary HealthcareVetpharma(Insud Pharma)
  • Alivira Animal Health Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Veterinary Active Pharmaceutical Ingredients (API) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Veterinary Active Pharmaceutical Ingredients (API) Market Dynamics
  1. 2.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Trends
  2. 2.2 Veterinary Active Pharmaceutical Ingredients (API) Industry Drivers
  3. 2.3 Veterinary Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges
  4. 2.4 Veterinary Active Pharmaceutical Ingredients (API) Industry Restraints
3 Veterinary Active Pharmaceutical Ingredients (API) Market by Manufacturers
  1. 3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Veterinary Active Pharmaceutical Ingredients (API) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Active Pharmaceutical Ingredients (API) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers, Product Type & Application
  7. 3.7 Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Active Pharmaceutical Ingredients (API) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Active Pharmaceutical Ingredients (API) Tier 1, Tier 2, and Tier 3
4 Veterinary Active Pharmaceutical Ingredients (API) Market by Type
  1. 4.1 Veterinary Active Pharmaceutical Ingredients (API) Type Introduction
  2. 4.1.1 Biological API
  3. 4.1.2 Chemical Based API
  4. 4.1.3 Highly Potent APl(HPAPI)
  5. 4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type
  6. 4.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2032)
  8. 4.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type
  10. 4.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2032)
  12. 4.3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2021-2032)
5 Veterinary Active Pharmaceutical Ingredients (API) Market by Application
  1. 5.1 Veterinary Active Pharmaceutical Ingredients (API) Application Introduction
  2. 5.1.1 CDMO
  3. 5.1.2 CMO
  4. 5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application
  5. 5.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2032)
  7. 5.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2021-2032)
  8. 5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application
  9. 5.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2032)
  11. 5.3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2021-2032)
6 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region
  1. 6.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2021-2026)
  4. 6.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region
  1. 7.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region
  2. 7.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2021-2026)
  4. 7.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2027-2032)
  5. 7.1.4 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032)
  8. 7.2.2 North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032)
  11. 7.3.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
  2. 8.1.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information
  3. 8.1.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Business Overview
  4. 8.1.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  6. 8.1.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments
  7. 8.2 Jiangsu Lingyun Pharmaceutical Co. Ltd
  8. 8.2.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information
  9. 8.2.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Business Overview
  10. 8.2.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  12. 8.2.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments
  13. 8.3 SUANFARMAOfichem Group
  14. 8.3.1 SUANFARMAOfichem Group Company Information
  15. 8.3.2 SUANFARMAOfichem Group Business Overview
  16. 8.3.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  18. 8.3.5 SUANFARMAOfichem Group Recent Developments
  19. 8.4 Procyon Life Sciences
  20. 8.4.1 Procyon Life Sciences Company Information
  21. 8.4.2 Procyon Life Sciences Business Overview
  22. 8.4.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  24. 8.4.5 Procyon Life Sciences Recent Developments
  25. 8.5 NGL Fine-Chem Ltd
  26. 8.5.1 NGL Fine-Chem Ltd Company Information
  27. 8.5.2 NGL Fine-Chem Ltd Business Overview
  28. 8.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  30. 8.5.5 NGL Fine-Chem Ltd Recent Developments
  31. 8.6 Menadiona
  32. 8.6.1 Menadiona Company Information
  33. 8.6.2 Menadiona Business Overview
  34. 8.6.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  36. 8.6.5 Menadiona Recent Developments
  37. 8.7 lndukern Group
  38. 8.7.1 lndukern Group Company Information
  39. 8.7.2 lndukern Group Business Overview
  40. 8.7.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  42. 8.7.5 lndukern Group Recent Developments
  43. 8.8 LasaSupergenerics Ltd.
  44. 8.8.1 LasaSupergenerics Ltd. Company Information
  45. 8.8.2 LasaSupergenerics Ltd. Business Overview
  46. 8.8.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  48. 8.8.5 LasaSupergenerics Ltd. Recent Developments
  49. 8.9 Huvepharma
  50. 8.9.1 Huvepharma Company Information
  51. 8.9.2 Huvepharma Business Overview
  52. 8.9.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  54. 8.9.5 Huvepharma Recent Developments
  55. 8.10 Excel Veterinary HealthcareVetpharma(Insud Pharma)
  56. 8.10.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information
  57. 8.10.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Business Overview
  58. 8.10.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  60. 8.10.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments
  61. 8.11 Alivira Animal Health Ltd
  62. 8.11.1 Alivira Animal Health Ltd Company Information
  63. 8.11.2 Alivira Animal Health Ltd Business Overview
  64. 8.11.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  66. 8.11.5 Alivira Animal Health Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Active Pharmaceutical Ingredients (API) Value Chain Analysis
  2. 9.1.1 Veterinary Active Pharmaceutical Ingredients (API) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Active Pharmaceutical Ingredients (API) Production Mode & Process
  6. 9.2 Veterinary Active Pharmaceutical Ingredients (API) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Active Pharmaceutical Ingredients (API) Distributors
  9. 9.2.3 Veterinary Active Pharmaceutical Ingredients (API) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst